AlloVir Announces Viralym-M Granted Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT

95

HOUSTON–(BUSINESS WIRE)–AlloVir’s Viralym-M Granted RMAT Designation for Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT

 

 

http://www.businesswire.com/news/home/20190611005235/en/AlloVir-Announces-Viralym-M-Granted-Regenerative-Medicine-Advanced/